1. Home
  2. CTMX vs IH Comparison

CTMX vs IH Comparison

Compare CTMX & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • IH
  • Stock Information
  • Founded
  • CTMX 2008
  • IH 1996
  • Country
  • CTMX United States
  • IH China
  • Employees
  • CTMX N/A
  • IH N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • IH Other Consumer Services
  • Sector
  • CTMX Health Care
  • IH Real Estate
  • Exchange
  • CTMX Nasdaq
  • IH Nasdaq
  • Market Cap
  • CTMX 444.3M
  • IH 123.1M
  • IPO Year
  • CTMX 2015
  • IH 2020
  • Fundamental
  • Price
  • CTMX $2.42
  • IH $2.28
  • Analyst Decision
  • CTMX Strong Buy
  • IH
  • Analyst Count
  • CTMX 2
  • IH 0
  • Target Price
  • CTMX $5.00
  • IH N/A
  • AVG Volume (30 Days)
  • CTMX 2.4M
  • IH 18.3K
  • Earning Date
  • CTMX 08-07-2025
  • IH 06-26-2025
  • Dividend Yield
  • CTMX N/A
  • IH 3.70%
  • EPS Growth
  • CTMX 128.27
  • IH N/A
  • EPS
  • CTMX 0.49
  • IH 0.26
  • Revenue
  • CTMX $147,557,000.00
  • IH $123,701,096.00
  • Revenue This Year
  • CTMX N/A
  • IH $39.02
  • Revenue Next Year
  • CTMX N/A
  • IH N/A
  • P/E Ratio
  • CTMX $5.36
  • IH $8.74
  • Revenue Growth
  • CTMX 23.81
  • IH N/A
  • 52 Week Low
  • CTMX $0.40
  • IH $1.47
  • 52 Week High
  • CTMX $3.10
  • IH $3.18
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 52.71
  • IH 43.26
  • Support Level
  • CTMX $2.33
  • IH $2.20
  • Resistance Level
  • CTMX $2.79
  • IH $2.70
  • Average True Range (ATR)
  • CTMX 0.18
  • IH 0.13
  • MACD
  • CTMX -0.01
  • IH -0.02
  • Stochastic Oscillator
  • CTMX 46.38
  • IH 14.42

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

Share on Social Networks: